Avery Trim1, Susan E Hankinson1, Simin Liu2, Aladdin H Shadyab3, Jaymie Meliker4, Wei Bao5, Juhua Luo6, Buyun Liu5, JoAnn E Manson7, Lesley Tinker8, Carol Bigelow1, Katherine W Reeves9. 1. Department of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, MA, USA. 2. Center for Global Cardiometabolic Health, Departments of Epidemiology, Medicine and Surgery, Brown University, USA. 3. Department of Family Medicine and Public Health; University of California San Diego School of Medicine; La Jolla, CA, USA. 4. Program in Public Health, Department of Family, Population, & Preventive Medicine, Stony Brook University, Stony Brook, NY, 11794, USA. 5. Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, 52242, USA. 6. Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, IN, 47405, USA. 7. Department of Medicine, Brigham and Women's Hospital, Harvard Medical School and the Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02215, USA. 8. Division of Public Health Sciences, Department of Cancer Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA. 9. Department of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, MA, USA. Electronic address: kwreeves@umass.edu.
Abstract
BACKGROUND: Recent experimental work has shown that phthalates may increase inflammation. Prior research has not examined the role of exposure to phthalates in relation to inflammatory status among postmenopausal women who are at higher risk of developing inflammation-related chronic disorders. OBJECTIVES: We aimed to examine the associations of urinary phthalate biomarker concentrations with circulating levels of c-reactive protein [CRP] and interleukin-6 [IL-6] among 443 postmenopausal women selected into a breast cancer case-control study nested within the Women's Health Initiative (WHI). METHODS: A total of 13 phthalate metabolites were measured in urine samples provided at WHI enrollment from 1993 to 1998. We also measured baseline levels of CRP and IL-6 in these women's serum or plasma samples. Multivariable linear models were used to investigate the role of each phthalate biomarker in relation to CRP and IL-6, adjusting for potential confounding factors and specifically evaluating the role of BMI. RESULTS: In adjusted models we observed positive associations of monocarboxynonyl phthalate (MCNP) with CRP (β = 0.092; 95% CI 0.026, 0.158) and IL-6 (β = 0.108; 95% CI 0.013, 0.204). These positive associations were attenuated and non-significant, however, after further adjustment for body mass index (BMI). In contrast, we observed inverse associations of monoethyl phthalate (MEP) (β = -0.019; 95% CI -0.036, -0.001) and monobenzyl phthalate (MBzP) (β = -0.034; 95% CI -0.058, -0.010) with CRP levels only after adjustment for BMI. Other phthalate biomarkers examined were not significantly associated with either CRP or IL-6 levels. CONCLUSIONS: Overall, these results do not suggest an important role for phthalates in promoting an inflammatory response. Future prospective studies are warranted to improve understanding of these associations, particularly in clarifying the role of BMI.
BACKGROUND: Recent experimental work has shown that phthalates may increase inflammation. Prior research has not examined the role of exposure to phthalates in relation to inflammatory status among postmenopausal women who are at higher risk of developing inflammation-related chronic disorders. OBJECTIVES: We aimed to examine the associations of urinary phthalate biomarker concentrations with circulating levels of c-reactive protein [CRP] and interleukin-6 [IL-6] among 443 postmenopausal women selected into a breast cancer case-control study nested within the Women's Health Initiative (WHI). METHODS: A total of 13 phthalate metabolites were measured in urine samples provided at WHI enrollment from 1993 to 1998. We also measured baseline levels of CRP and IL-6 in these women's serum or plasma samples. Multivariable linear models were used to investigate the role of each phthalate biomarker in relation to CRP and IL-6, adjusting for potential confounding factors and specifically evaluating the role of BMI. RESULTS: In adjusted models we observed positive associations of monocarboxynonyl phthalate (MCNP) with CRP (β = 0.092; 95% CI 0.026, 0.158) and IL-6 (β = 0.108; 95% CI 0.013, 0.204). These positive associations were attenuated and non-significant, however, after further adjustment for body mass index (BMI). In contrast, we observed inverse associations of monoethyl phthalate (MEP) (β = -0.019; 95% CI -0.036, -0.001) and monobenzyl phthalate (MBzP) (β = -0.034; 95% CI -0.058, -0.010) with CRP levels only after adjustment for BMI. Other phthalate biomarkers examined were not significantly associated with either CRP or IL-6 levels. CONCLUSIONS: Overall, these results do not suggest an important role for phthalates in promoting an inflammatory response. Future prospective studies are warranted to improve understanding of these associations, particularly in clarifying the role of BMI.
Authors: Katherine W Reeves; Mary Díaz Santana; JoAnn E Manson; Susan E Hankinson; R Thomas Zoeller; Carol Bigelow; Susan R Sturgeon; Donna Spiegelman; Lesley Tinker; Juhua Luo; Bertha Chen; Jaymie Meliker; Matthew R Bonner; Michele L Cote; Ting-Yuan David Cheng; Antonia M Calafat Journal: J Natl Cancer Inst Date: 2019-10-01 Impact factor: 13.506
Authors: Peter Y Bai; Gary Wittert; Anne W Taylor; Sean A Martin; Robert W Milne; Alicia J Jenkins; Andrzej S Januszewski; Zumin Shi Journal: Environ Res Date: 2017-07-04 Impact factor: 6.498
Authors: Leonard T Rael; Raphael Bar-Or; Daniel R Ambruso; Charles W Mains; Denetta S Slone; Michael L Craun; David Bar-Or Journal: Oxid Med Cell Longev Date: 2009 Jul-Aug Impact factor: 6.543
Authors: Beth Ann Griffin; Christine Eibner; Chloe E Bird; Adria Jewell; Karen Margolis; Regina Shih; Mary Ellen Slaughter; Eric A Whitsel; Matthew Allison; Jose J Escarce Journal: Health Place Date: 2012-12-07 Impact factor: 4.078
Authors: Mary V Díaz Santana; Susan E Hankinson; Carol Bigelow; Susan R Sturgeon; R Thomas Zoeller; Lesley Tinker; Jo Ann E Manson; Antonia M Calafat; Jaymie R Meliker; Katherine W Reeves Journal: Environ Health Date: 2019-03-12 Impact factor: 5.984
Authors: Anne M Minihane; Sophie Vinoy; Wendy R Russell; Athanasia Baka; Helen M Roche; Kieran M Tuohy; Jessica L Teeling; Ellen E Blaak; Michael Fenech; David Vauzour; Harry J McArdle; Bas H A Kremer; Luc Sterkman; Katerina Vafeiadou; Massimo Massi Benedetti; Christine M Williams; Philip C Calder Journal: Br J Nutr Date: 2015-07-31 Impact factor: 3.718